Integral Health Asset Management’s Aclaris Therapeutics ACRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-225,000
| Closed | -$1.82M | – | 72 |
|
|
2023
Q1 | $1.82M | Sell |
225,000
-145,000
| -39% | -$1.17M | 0.37% | 63 |
|
|
2022
Q4 | $5.83M | Buy |
370,000
+30,000
| +9% | +$473K | 1.22% | 30 |
|
|
2022
Q3 | $5.35M | Buy |
340,000
+54,029
| +19% | +$850K | 1.04% | 39 |
|
|
2022
Q2 | $3.99M | Buy |
285,971
+47,971
| +20% | +$670K | 0.82% | 43 |
|
|
2022
Q1 | $4.1M | Buy |
238,000
+38,000
| +19% | +$655K | 1.07% | 35 |
|
|
2021
Q4 | $2.91M | Buy |
200,000
+15,000
| +8% | +$218K | 0.8% | 40 |
|
|
2021
Q3 | $3.33M | Buy |
185,000
+10,000
| +6% | +$180K | 0.96% | 46 |
|
|
2021
Q2 | $3.07M | Buy |
+175,000
| New | +$3.07M | 0.85% | 43 |
|